These data indicate that patients with type 2 diabetes carrying minor variants of LZTFL1 and RAVER1 (and probably also IFNAR2 and MUC5B) are more likely to have hospitalization-requiring COVID-19 than the general population. This evidence concerns the gene RAVER1 and COVID-19.